VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,612 | -62.4% | 25,836 | -42.6% | 0.01% | -75.5% |
Q2 2023 | $296,622 | +129.9% | 45,011 | +281.4% | 0.05% | +51.4% |
Q2 2022 | $129,000 | +8.4% | 11,803 | +12.4% | 0.04% | +9.4% |
Q1 2022 | $119,000 | -34.6% | 10,500 | -13.2% | 0.03% | -71.4% |
Q1 2021 | $182,000 | -26.6% | 12,100 | -20.1% | 0.11% | +47.4% |
Q4 2019 | $248,000 | – | 15,137 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |